Nobel Prize in Chemistry Honors Work on Chiral Molecules

The 2026 Nobel Prize in chemistry was awarded to Henri Kagan and Kenso Soai for their work on chiral molecules. Chirality is a property that affects how molecules interact with each other, and it has far-reaching implications in chemistry and medicine. Kagan and Soai's discoveries have helped to explain how life may have chosen one-handedness, and their work has significant implications for the development of pharmaceuticals. In medicine, controlling chirality is crucial, as a pharmaceutical molecule's handedness can determine its effectiveness and safety. For example, thalidomide's S-form was found to be the culprit behind birth defects, while ibuprofen's S-form is the active form that blocks enzymes producing chemical signals for pain and swelling. L-DOPA, a mainstay of Parkinson's treatment, is also a chiral molecule that must be administered in its correct form to be effective.